{"id":"NCT00348348","sponsor":"Bausch & Lomb Incorporated","briefTitle":"A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis","officialTitle":"A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vigamox in the Treatment of Bacterial Conjunctivitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2007-07","completion":"2007-07","firstPosted":"2006-07-04","resultsPosted":"2009-08-13","lastUpdate":"2015-03-24"},"enrollment":1161,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Bacterial Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Besifloxacin","otherNames":[]},{"type":"DRUG","name":"Moxifloxacin solution","otherNames":[]}],"arms":[{"label":"Moxifloxacin solution","type":"ACTIVE_COMPARATOR"},{"label":"Besifloxacin Suspension","type":"EXPERIMENTAL"}],"summary":"This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.","primaryOutcome":{"measure":"Clinical Resolution","timeFrame":"Day 5(+/- 1 day)","effectByArm":[{"arm":"Moxifloxacin Solution","deltaMin":167,"sd":null},{"arm":"Besifloxacin Suspension","deltaMin":147,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["32841261","20629472"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":579},"commonTop":[]}}